
HealthEquity (HQY) reported robust Q3 2025 results, with revenue of $325.84 million and EPS of $1.08, surpassing consensus estimates by 2.2% and 17.39% respectively. This strong financial performance was driven by significant growth in key underlying metrics, including total HSA assets reaching $33.14 billion and total accounts expanding to 17.14 million, both exceeding analyst projections. Custodial and interchange revenue streams also saw healthy year-over-year increases of 15.3% and 8%, underscoring solid business momentum despite the stock's recent -2% return against the S&P 500's +3.8%.
HealthEquity (HQY) reported a robust quarter, significantly surpassing analyst expectations. Revenue increased 8.6% year-over-year to $325.84 million, beating the consensus estimate by 2.2%, while EPS of $1.08 marked a substantial 17.39% surprise. The primary driver of this outperformance was the Custodial revenue segment, which surged 15.3% YoY to $159.88 million, indicating strong monetization of its asset base. This was complemented by solid beats in key operational metrics, including Total HSA Assets ($33.14B vs. $32.48B est.) and Total Accounts (17.14M vs. 16.97M est.). However, the results contained points of weakness that warrant attention. The company posted a slight miss on its number of HSAs Accounts (9.99M vs. 10.1M est.) and saw anemic growth of just 1% in its Service revenue segment. Furthermore, while Total HSA investments strongly beat forecasts, Total HSA cash missed estimates ($17.04B vs. $17.7B est.), suggesting a potential mix shift by customers. Despite the strong headline numbers, the stock's -2% return over the past month, underperforming the S&P 500, suggests the market may be focusing on these nuanced weaknesses or had already priced in the positive results.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment